Literature DB >> 2536346

Analysis of hepatitis B virus transcripts in infected human livers.

T S Su1, W Y Lui, L H Lin, S H Han, F K P'eng.   

Abstract

The hepatitis B virus transcripts in human hepatoma and its adjacent nontumorous liver were examined with probes specific to hepatitis B virus surface antigen, core antigen, X region and pre-S region. The study shows that the patterns of hepatitis B virus transcripts for tumorous tissue and the counterpart in nontumorous liver differ. In most of the tissues examined, the surface antigen gene is transcribed. Most of these transcripts, besides having surface antigen sequences, also have an X region; some also include a pre-S region. The transcripts that hybridized to a core-specific probe were a pair of poly(A+) RNA, 3.5 and 2.2 kilobases in size, present in two of the nontumorous hepatocytes where the virus was actively replicating. The 3.5-kilobase transcript not only hybridized to the core probe, but was able to be hybridized to other hepatitis B virus subgenomic probes and might represent the RNA pregenome involving hepatitis B virus DNA replication. Whereas most of the transcripts hybridizable to hepatitis B virus probe are in the size range of 2.1 to 2.7 kilobases, some transcripts other than the pregenomic RNA appear to be greater than 3.2 kilobases in size and may represent the hybrid RNAs of viral and host sequences.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536346     DOI: 10.1002/hep.1840090203

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  26 in total

1.  The cytoplasmic HBVDNA implication: HBV replication or non-replicative status.

Authors:  Y Y Zhang; P Yan; Z Q Yu; Y K Wang; L J Hao
Journal:  J Tongji Med Univ       Date:  1990

2.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA.

Authors:  C Hilger; I Velhagen; H Zentgraf; C H Schröder
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  A splice hepadnavirus RNA that is essential for virus replication.

Authors:  S Obert; B Zachmann-Brand; E Deindl; W Tucker; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

5.  In vivo transmission and dynamics of deleted genomes after experimental infection of woodchuck hepatitis B virus in adult animals.

Authors:  Valentina La Sorsa; Claudio Argentini; Roberto Bruni; Umberta Villano; Roberto Giuseppetti; Maria Rapicetta
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

6.  Complementarity between epsilon and phi sequences in pregenomic RNA influences hepatitis B virus replication efficiency.

Authors:  Claudia E Oropeza; Alan McLachlan
Journal:  Virology       Date:  2006-10-23       Impact factor: 3.616

7.  Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal.

Authors:  Nuruddin Unchwaniwala; Nathan M Sherer; Daniel D Loeb
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

8.  Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor.

Authors:  A K Raney; H B Le; A McLachlan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1.

Authors:  A K Raney; A J Easton; D R Milich; A McLachlan
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter.

Authors:  P Zhang; A K Raney; A McLachlan
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.